Kossan Rubber Industries

Kossan Rubber Industries - Reviews & Target Price

ss20_20
Publish date: Sat, 03 Jan 2015, 02:15 PM
ss20_20
0 155
坚守长期价值投资, 催化复利累进效应, 实现财务自主与享受写意人生
Value Investing & Joys of Compounding
___________________________________________________________________

ss2020 - Blog Title List | 目录:
http://klse.i3investor.com/blogs/ss2020_List/
____________________________________________________________________

以下纯粹个人投资收集与记录,且本人非专业分析员,买卖亏盈自负。
The articles here solely the collection or opinion of the author and do not represent professional advice in investment

 




 


 


Kossan Rubber - Unveiling The Expansion Plan

 

 


(吉隆坡25日訊)

 

受馬幣兌美元匯率升破4.20令吉打擊,早前在“強勢美元”主題下備受追捧的手套股週三慘遭拋售,股價全面淪陷,使投資者惶惶不安,擔心強勢美元投資風可能正醞釀轉向。

 

手套股受惠於強勢美元和產能增加,成了今年馬股的“搶手貨”之一,也是美元投資風下的代表股類,開年至今平均上揚近70%;然而,雖然業績報捷、繼續廣受證券行看好,但隨馬幣近期轉強,手套股股價遂顯得有氣無力,紛紛出現調整。

 

 

頂級手套跌36仙

其中,近期氣焰最盛的頂級手套(TOPGLOV,7113,主板工業產品組)就在週三大跌36仙或3.73%;高產尼品(KOSSAN,7153,主板工業產品組)也跌48仙或5.66%;賀特佳(HARTA,5168,主板工業產品組)則跌34仙或5.88%,全數入圍10大下跌榜。

 

此外,速柏瑪(SUPERMX,7106,主板工業產品組)也下跌9仙或3.7%;康复手套(COMFORT,2127,主板工業產品組)和業績遜色的加護手套(C A R E P L S,0163,創業板工業產品組),也各跌1.28%和5.75%。

 

無論如何,估值高企和股價今日回調讓投資者擔心手套股已陷入“高處不勝寒”窘境,甚至擔心“強勢美元”再無法獨自撐起手套股估值。

 

未來6至9個月仍有看頭

《星洲財經》向行內人士查詢後發現,在原料成本低企和美元走強等雙重利好的支持下,手套股未來6至9個月的業績仍有看頭,但由於股價已提前反映利好,出現套利是正常的結果。

 

“馬幣近期重新站穩,兌美元匯率從4.40令吉下滑至4.20令吉,影響了強勢美元主題股的投資情緒,驅使投資者趁高套利,因此相信若馬幣繼續走強,靠強勢美元撐場的公司股價短期內還有回跌空間,尤其是那些估值偏高和股價累積可觀漲幅的公司。”

 

數據顯示,馬股手套股今年至今全數報漲,漲幅介於16至113%之間,平均漲幅為70%,明顯跑贏大市,其中漲最兇的是頂級手套,漲最少的則是今年中剛脫離PN17的康复手套。

 

不過,Arena資本首席執行員黃德明受訪時認為,全球手套需求量持續走高、原料價格疲弱,再加上美元持強,手套業今年表現預計會相當不錯。

 

他認為,只要馬幣兌美元匯率無法在2016年恢復至3.30令吉水平,手套公司的淨利都不會受太大影響,即使馬幣匯率回揚至3.60至3.80令吉之間,因手套業者的淨利主要由營業額成長帶動

 

“美元走強,對手套業者而言只是錦上添花而已。”

 

輝立資本首席策略員潘力克表示,手套領域的估值雖已有高估跡象,雖然需求走高仍可持續扶持股價,但若未來業績低於市場預期,則可能面對賣壓風險。

 

最新一季業績顯示,上月公佈業績的頂級手套單季淨利飆漲123%至1億零311萬9千令吉,創史上最高紀錄。而本月初公佈業績的高產尼品及賀特佳,淨利則各揚60.35%和25.43%,繼續受惠於強勢美元。

不過,加護手套昨日公佈的業績表現平平,雖按年轉虧為盈,但淨利只有32萬3千令吉。

 

目前,尚未公佈業績的手套股只剩速柏瑪和康复手套,兩家公司料在未來幾天內發佈業績。

 

 

星洲日報/報道:李三宇、謝汪潮

 


Kossan Rubber Industries - Party not over yet TP = RM10.20

Author: kltrader   |   Publish date: Fri, 20 Nov 2015, 12:38 PM 


  • 3Q15 net profit (+16% QoQ, +60% YoY) within expectations.
  • Demand for nitrile glove remains solid with high take-up rates for its new capacities.
  • Maintain BUY with a higher TP of MYR10.20 (25x 2017 PER).

What’s New

3Q15 net profit of MYR55m (+16% QoQ, +60% YoY) brought 9M15 net profit to MYR148m (+40% YoY), making up 72% and 73% of our and street’s full-year estimates. The results is with expectations as we expect a slightly stronger 4Q15. A first interim tax exempt dividend of 5.5sen/shr has been declared (+57% YoY).

Key takeaways from 3Q15 results: (i) the stronger revenue (+15% QoQ, +35% YoY) was largely driven by growth in its key glove manufacturing segment (+16% QoQ, +35% YoY) on strong volume growth (+10% QoQ, +33% YoY); (ii) overall pretax profit growth surpassed that of topline on higher pretax margins (+0.4-ppt QoQ, +2.3-ppt YoY) with margin improvements across all segments YoY on lower input cost and higher operating leverage.

What’s Our View

Kossan’s overall plant utilisation rate remains high at >80% as the new Plant 1-3 (commenced in Aug 2014-Jun 2015) achieved high take-up rates. Going forward, we expect stronger earnings on volume growth for the demand of nitrile gloves remain strong and there will be full-year contribution from Plant 1-3 in FY16 (capacity growth: 33%). Maintain our earnings forecasts.

Given the strong appetite for glove stocks, we raise our target PER for Kossan to 25x (from 22x; on par to our PER target for Hartalega as operating and financial parameters of Kossan is catching up) and roll forward our valuation to end-2017 (from mid-2017) to derive our new TP of MYR10.20 (+23%).

Source: Maybank Research - 20 Nov 2015


Kossan - Solid 3Q15 But Valuations Stretched TP = RM9.11

Author: kiasutrader   |   Publish date: Fri, 20 Nov 2015, 11:10 AM 


Period

3Q15/9M15

Actual vs. Expectations

9M15 net profit of RM148m (+40% YoY) came in within expectations, at 72% of our and consensus full-year forecasts, respectively.

Dividends

A first single-tier interim dividend of 5.5 sen was declared. Key Result

Highlights

QoQ, 3Q15 revenue rose 15% due largely to contribution from gloves division, which accounted for more than 87% of total revenue. Specifically, gloves revenue rose 16% due to higher volume growth (10% QoQ; 33% YoY) on the back of 85% utilisation rate which more than offset lower ASP. This brings 3Q15 net profit to RM55.2m (+16% QoQ). Note that the product mix of nitrile and natural rubber in 3Q15 is 70:30 compared to 68:32 in 2Q15.

YoY, 9M15 revenue rose 28% to RM1.2b thanks to higher glove sales volume (+34%) and higher RM ASPs due to the weaker USD against MYR. Higher volume sales, better product mix (the product mix of nitrile and natural rubber for 9M15 was 68:32 (versus 60:40 of FY2014) and improved operational efficiency led to 9M15 EBITDA margin of 20.5% compared to 19.4% in 9M14. This brings 9M15 PATAMI to RM148m.

Outlook

Looking ahead, growth in subsequent quarters are to be driven by Plant 2 and 3 with 4b pieces per annum of capacity expected to be running at full capacity. We understand that clients have been found for the new capacity. This brings the three new plants installed capacity to 22b from 16b per pieces of gloves per annum.

We understand that another phase of expansion is expected due to overwhelming demand for various glove products. Recall, at end-Dec 2014, Kossan acquired a piece of freehold industrial land measuring 13.3 acres located in Kapar, for a cash consideration of RM39m. We also understand that the land is earmarked for two manufacturing glove plants and a warehouse.

Change to Forecasts

No changes to our earnings forecasts.

Rating & Valuation

We roll over our valuation from FY16E to FY17E. Correspondingly our target price is raised from RM8.16 to RM9.11 based on unchanged 22x FY17 EPS. Since our Outperform recommendation back in early year 2013, the stock has risen by five fold. In terms of YTD 2015 performance, the stock has gained 99%.

We like Kossan for: (i) its superior net profit growth of 43% and 15% in FY15E and FY16E, respectively, and (ii) the unprecedented earnings growth over the next two years underpinned by rapid capacity expansion. However, valuations appeared stretched trading at +2.0 SD above the 5-year historical mean. Hence, we are downgrading its rating to Market Perform.

Risks

Delay in commissioning of new production lines.

Source: Kenanga Research - 20 Nov 2015


Rubber Gloves - Positive surprise from Budget 2016 OVERWEIGHT

Author: kiasutrader   |   Publish date: Tue, 27 Oct 2015, 11:05 AM


- We see the rubber glove manufacturers as prime beneficiaries of Budget 2016 in view of the proposal for a Special Reinvestment Allowance (RA) Incentive for companies that have exhausted their eligibility to qualify for RA. The rate of claim is at 60% of qualifying capex and can be set off against 70% of statutory income from year of assessment 2016 to 2018.

- This proposal is particularly significant for the rubber glove players as most had expired their RA incentives (valid for 15 consecutive years from the year of assessment RA is claimed) between 2012 and 2014 considering their long operating history.

- Such an incentive is also timely for the glove manufacturers given their current capex upcycle. Against the backdrop of robust global glove demand (+9% YoY), we understand that the top four glove manufacturers have allocated capex of RM150mil to RM400mil p.a. for the next three years to boost installed capacity by ~11% p.a.

- The reinstatement of RA essentially means that the effective tax rates of glove companies could be lowered, leading to higher earnings moving forward. Historical data show that the effective tax rates for the top four players averaged at 16% prior to the RA expiries vs. the current 23%. Assuming a conservative 4ppts reduction to the forward effective tax rates, i.e. at 19%, we estimate an average earnings upside of 4%-7% p.a. for the rubber glove players.

- This announcement lends further credence to our OVERWEIGHT call on the rubber gloves sector. We expect the sector to enjoy another round of PE re-rating, with its premium valuations justified by its prime position as exporters operating in a defensive sector and the fact that it is one of the few industries in the market that is experiencing positive earnings upgrades from volume growth and margin expansion.

- While other points in the budget referred to potential cost inflations for the glove manufacturers, namely the 11% hike in the Peninsula Malaysia minimum wage from RM900 to RM1,000 and increase in the floor price of SMR20 and cuplumps, we are not too concerned as:- (1) labour costs make up only ~10% of the glove manufacturers’ total operating costs; (2) the industry has a cost pass-through pricing mechanism; (3) there is an eight-month grace period to the implementation date; and (4) usage of imported bulk latex vs. domestic SMR20 as inputs.

- The latest rally of the rubber glove counters last week saw their share prices once again exceeding our fair values (all except Top Glove’s and by 9% on average). This was despite our constant upward revisions (between two to six times) since our sector upgrade in December 2014. Pending further details from the managements and the share price overshoots, which we view as a positive testament to our BUY calls, we are placing our current fair values for Top Glove Corp (RM10.60/share), Kossan Rubber (RM8.40/share), Hartalega Holdings (RM4.70/share) and Supermax Corp (RM2.05/share) under review.

Source: AmeSecurities Research - 26 Oct 2015

 


Kenanga Research | 06 Oct 2015


 


AmResearch maintains Buy on Kossan, ups fair value to RM8.40

 
Printer-friendly versionSend by emailPDF version

KUALA LUMPUR (July 28): AmResearch Sdn Bhd has reaffirmed its “Buy” rating on Kossan Rubber Industries Bhd ( Financial Dashboard) with a higher fair value of RM8.40 to reflect the research house’s upward revised FY15F-FY17F earnings estimates and higher FY15F PE target of 27x (on par with Hartalega Holdings ( Financial Dashboard)’ PE given its comparable operational and financial performance).

In a note today, the research house said its Buy recommendation on Kossan was premised on:- (1) its superior earnings growth and track record (3-year CAGR of 22%); (2) margin expansion on the back of an improving product mix and operating efficiencies; (3) favourable USD:RM exposure; and (4) upcoming restructuring of its TRP division.

“While there was a slight commercial production delay in the group’s newly constructed Plant 2 and 3 (to June 2015, capacity of about 2 billion pieces each), we do not expect this to significantly impact earnings as it should be more than offset by its margin improvements.

“The new capacity, which will be commissioned progressively, will result in a stronger 2HFY15 for Kossan and help boost full-year FY15F earnings by 40% year-on-year,” it said.

“Although Kossan’s share price had performed exceedingly well year-to-date (outperforming its peers and market by 17% and 63% respectively), we believe that the stock has further upside given the imminent US rate hike as well as potential moves by management to reward its shareholders given its improving cash flows,” it said.


 

Malaysia Gloves Sector - Re-rating to continue

Author: kltrader   |   Publish date: Tue, 21 Jul 2015, 11:22 AM


  • ASP competition has eased - new capacity well absorbed by new demand.
  • Sector will continue to benefit from the strengthening USD.
  • Re-rating to continue; remain OVERWEIGHT; BUY Top Glove and Kossan with higher TPs of MYR9.10 and MYR7.20.

What’s New

Share prices of glove producers have appreciated substantially, +23-72% YTD, outperforming the KLCI by 45% on a relative basis. Similarly, valuations have also re-rated upward with 1-year rolling forward PERs of 16-24x presently (from 11-21x in end-Dec 2014).

What’s Our View

The strong share price performance has been driven by both internal (i.e. strong financial results due to higher efficiencies, higher sales volume) and external (i.e. rising USD) factors.

Additionally, ASP competition within the nitrile space has eased in recent months, for the new supply has been well-absorbed by new demand/rising outsourcing orders. The Malaysia glove producers have also marginally raised their ASPs (by <1%) to fully pass on the higher gas tariff hike (effective Jul 2015).

Looking ahead, we expect the glove stocks to still perform well on strong near-term earnings growth, underpinned by new capacities and higher margins due to improved efficiencies and continuous USD strength. We maintain our earnings forecasts for Hartalega and Kossan, but raise Top Glove’s FY8/16-17 EPS by 8-13% in view of its fast capacity expansion ahead.

Hartalega remains a HOLD with an unchanged TP of MYR8.50 (22x 2016 PER). We continue to recommend a BUY on Top Glove and Kossan but with higher TPs of MYR9.10 (+28%) and MYR7.20 (+5%), on higher target PERs of 20x to both stocks (from 17x and 19x), which would still be 10% below our target PER for Hartalega. We expect the valuation gap to narrow principally on relatively stronger near-term earnings growth; the discount to Hartalega is to reflect its dominant position in the nitrile gloves segment.

Source: Maybank Research - 21 Jul 2015

http://cdn1.i3investor.com/my/files/dfgs88n/2015/07/22/1482985273-217783959.pdf

 


Kossan Rubber Industries - Stronger Earnings Visibility

Author: kiasutrader   |   Publish date: Tue, 21 Jul 2015, 09:17 AM


We met with Kossan’s management recently for an update on the company. Maintain NEUTRAL, with a higher TP of MYR7.08 (from MYR6.35, 5.0% upside). The company shared its long-term plans to build five plants that would more than double total glove production capacity to 50bn pieces pa by FY21, from 22bn pieces currently.

Capacity expansion. Kossan Rubber Industries (Kossan) shared its plans to build five plants on the 57 acres of land in Batang Berjuntai that was purchased back in Feb 2013. Construction could start as early as 2H16, with capacity gradually coming online throughout FY18-21. After that, its total glove capacity will more than double to 50bn pieces pa from the 22bn pieces currently.

Earnings visibility. Management expects a stronger earnings profile in the 2H15 on the back of stronger contributions from Plant 2 & 3, a higher degree of automation and more effective cost control. While it initially did not anticipate any glove capacity expansion in 2016, it now expects up to an additional capacity of 1bn pieces as a result of revamping of old manufacturing lines during the year. We believe that marginimprovements going forward would be sustainable on the back of improving operating efficiencies as well as higher mix of nitrile gloves.

Cost pressures. Kossan also shared that the impact from the recent increase in natural gas tariffs to MYR21.8 per million British thermal units (MMBtu) from MYR19.77/MMBtu would be manageable as the cost would be passed through to its clients within 1-3 months. Natural gas accounts for 6% of the company’s total costs.

Earnings forecast & risk. After adjusting our assumptions, we upgrade our FY15-24 earnings forecasts by 3%-16%. The key downside risk to our forecasts remains the heightened completion within the industry that could lead to lower ASPs and margins, while upside risks include afurther weakening of the MYR.

 

Maintain NEUTRAL. While Kossan’s growth prospects are intact with a 19% EPS CAGR for FY15-17, we believe that this has been priced in atcurrent levels where the stock has returned an impressive +50% YTD. Kossan currently trades at 19.2x FY16F P/E, slightly below its historical 2SD trading band of 20.4x P/E. We reiterate our NEUTRAL recommendation with a revised DCF-based TP of MYR7.08 (COE: 9%, TG: 2%), which also implies a FY16F P/E of 20.3x

 

 

 


 

 


 


 


 

 


 

KOSSAN NOTES 1QTR2015

 


 

 



 


 

 



 

 

 

 

 

 





Rubber Products - Rubber Products

Date: 31/12/2014 

Source  :  RHB-OSK
Stock  :  HARTA       Price Target  :  8.04      |      Price Call  :  BUY
        Last Price  :  7.00      |      Upside/Downside  :   +1.04 (14.86%)
 
Source  :  RHB-OSK
Stock  :  KOSSAN       Price Target  :  5.12      |      Price Call  :  BUY
        Last Price  :  4.51      |      Upside/Downside  :   +0.61 (13.53%)
 
Source  :  RHB-OSK
Stock  :  TOPGLOV       Price Target  :  5.06      |      Price Call  :  BUY
        Last Price  :  4.60      |      Upside/Downside  :   +0.46 (10.00%)
 


We  maintain  our  OVERWEIGHT  call  on the rubber  products  sector  on the  back  of  a  favourable  structural  and  macroeconomic  environment. We  believe  earnings  will  be  capacity  driven  while  operating  efficiency will  be  required  to  outperform  peers.  As  such  we  like  Hartalega  and Kossan  for  their  economies  of  scale,  leadership  in  the  nitrile  glove segment and accelerated capex cycle.

Resilient  demand.  Global  glove  consumption  is  expected  to  remain strong,  led by demand from the healthcare segment,  and is anticipated to expand  8-10% per annum. Demand is  often touted as inelastic due to the  crucial  protective  role  that  gloves  provide,  especially  for  the healthcare sector. Thus, glove suppliers have a resilient earnings profile combining defensive qualities with steady earnings growth.

Additional  capacity.  We  believe  that  the  additional  capacity  from  the expansion  in  nitrile  production  will  be  absorbed  by  the  market.  The commissioning  of  new  production  lines  is  being  done  progressively, which  will  enable  the  glove  makers  to  time  upcoming  capacity  to  the prevailing demand landscape.  

USD  strength  is  a  boon.  The  strength  in  USD/MYR  will  benefit  the industry because revenue will have a greater sensitivity to the  greenbackrelative to costs. A 3% increase in the USD/MYR exchange rate could liftthe industry’s earnings by ~2-4%.

Karex  (KAREX  MK).  We  maintain  our  BUY  recommendation  on  the stock as we continue to like its  organic and inorganic  growth  potential. We  have a  higher  TP of MYR3.89  (from MYR3.43), ie 20x  FY16F P/E and a 14.4% upside,  on the back of  an expected 3-year FY14-17F EPS CAGR of 23.8%.

Risks.  Heightened competition among glove players could lead to lower ASPs  and margins  that, in particular, would not bode  well for Top Glove(TOPG MK, BUY, TP: MYR5.06)  and Supermax  (SUCB MK, BUY, TP: MYR1.87) as both are margin laggards in the industry.

Maintain  OVERWEIGHT.  We  continue  to  like  stocks  in  the  rubber products  sector  that have good earnings growth, strong balance sheets and decent dividend yields. Our Top Picks are Hartalega (HART MK, TP: MYR8.04),  Kossan  Ruber Industries (Kossan)  (KRI MK, TP: MYR5.12)and Karex. Maintain OVERWEIGHT.

Demand – Supply Structure

Demand Structure.  Global glove consumption is expected to remain resilient  –  led by demand from the healthcare segment  –  and the street  anticipates this  to expand 8-10% annually over the next few years. This demand will be supported by organic growth  from  the  developed  glove markets  such  as the  US  and  EU,  as  well  as  the rising healthcare spending levels in the emerging markets. Glove demands are often touted as inelastic due to the crucial protective role that gloves provide, especially for the  healthcare  sector.  This  has  been  further  reinforced  by  progressively  stringent health  regulations  imposed  by  countries.  Thus,  glove  suppliers  have  a  resilient earnings profile that makes them suitable for a defensive theme play.

 

Overall  increase  in  healthcare  awareness  and  hygiene  standards  will  continue  to encourage  glove  consumption,  especially  in  the  emerging  markets.  Per  capita consumption of  gloves  in the  Asia  and  China markets  is  trailing, representing  only 2.8% of the per capita consumption in the US (see Figure 2). Assuming that the glove usage  in  Asia  and  China  reaches  levels  utilised  in  the  EU,  both  Asia  and  China markets  could  potentially  be  as  large  as  470bn  pieces.  This  is more  than  2.5x  the current global glove market.

Unpleasant catalyst.  The recent Ebola virus outbreak in West Africa may create an unpleasant catalyst in glove demand. The latest official update  on 26 Dec  reported 19,000  cases  of  Ebola  infection  in  Africa  with  7,600  deaths.  Nevertheless,  our channel  checks  with  sources indicate  that  they  have  not  seen  any  surge  in  orders yet,  though queries  were increasing. Nonetheless, in the longer term, we thi nk that the epidemic will help to improve healthcare awareness, which, in turn, will contribute to resilient glove demand

Additional  capacity.  Amidst  the  robust  growth  in  rubber  glove  consumption,  the industry  is  also  experiencing  a  shift  in  user  preferenc e  from  latex  gloves  towards nitrile  ones.  This  shift is  due  to the  increasing rate  of  latex  allergy  among medical professionals. Major developed markets had experienced negative to minimal growth for  the  latex  gloves  segment  while  recording  large  positive  growth  for  the  nitrile equivalent in the last few years (see Figure 3). This shift is also reflected in Malaysian rubber  gloves  exports,  which  constitutes  roughly  60%  of  the  global  glove  market. Since 2008, nitrile gloves – as a percentage of Malaysian gloves exports – have seen their proportion increase to 50.2% in 2013 from 17.3% in 2008 (see Figure 4).

 

Major  Malaysian  glove  suppliers  have  been  aggressively  expanding  their  nitrile production in light of this shift in user preference. We forecast a 19bn pieces capacity expansion in 2015, ie a 21% growth from 2014 numbers.

 

 

This expansion has sparked fears of a supply glut. Nevertheless, we believe that the additional  capacity from the  expansion in  nitrile  production will be  absorbed  as  the commissioning of new production lines is  being done progressively. This,  in turn,  will enable  the  glove  makers  to  time  upcoming  capacity  to  the  prevailing  demand landscape.

Given  the  competitive  operational  environment,  major  Malaysian  glove  suppliers have  thus  far  managed  their  respective  expansion  plans  well  to  prevent  an oversupply  in the  market. As such, we expect much of the same strategy from them going forward. We believe that the glove suppliers  will  be proactive with regards to their upcoming capacity should demand  be  softer. Furthermore, we believe that the advocates  of  an  oversupply  scenario  have  not  fully  discounted  risks  of  possible capacity delays or unscheduled interruptions to existing  capacity such as those that plagued Supermax in the last four years.


Halyard Health Inc, formerly known as the healthcare division of Kimberly-Clark Corp (KMB US, NR), has announced plans to shut down one of its glove manufacturing plants  in Thailand that has  3bn  pieces  annual capacity by 2H15. This  ought to  help ease some of the additional capacity worries.

Margin Analysis
Competitive pressure  on margins.  While  we  do  not  expect  a  supply  glut,  we  do forecast  for  competition  between  glove  suppliers  to  heat  up  with  the  expected additional capacity. As with 2014, the increased competition will lead to lower ASPs as well as erosions in margins. Should heightened competition for sales volume lead to a price war, we believe that  Hartalega  –  the industry leader in  margins  –  will be poised to benefit the most.  As such, we believe that improving efficiency will be the key to outperforming peers.

Cost pressure. Nonetheless, unlike 2014 where the margins of rubber glove industry were  beset  by  tariff  hikes  in  electricity  (+15%)  and  natural gas  (+21%),  we  do  not foresee  significant  cost  headwinds  for  glove  suppliers  in  2015.  Prices  of  raw materials  are  forecasted  to  remain  subdued.  The  weaker  demand  and  stronger supply situation in the rubber market is expected to persist, thus keeping prices of natural  latex  low.  Meanwhile,  the  current  oil  price  weakness,  from  which  nitrile  is derived, is expected to keep prices of the latter favourable as well.

The  introduction  of goods and  services  tax  (GST)  will  have minimal impact  on the rubber glove industry,  as a significant amount of production is exported, thus  it is a zero-rated output tax.

 

Strength  of USD/MYR is a boon.  Expectations of interest rate normalisation in the US as well as a weaker Malaysian fiscal position, led by the fall in oil prices, have caused the MYR to weaken against the USD. As at 26 Dec, the USD/MYR exchange rate has appreciated 10.6% since 1 Sep 2014. The strength in USD/MYR will benefit the  rubber  glove  industry  because:  i)  the  rubber  glove  industry  is  predominantly export oriented  –  we predict 85-95% of total production  is  earmarked for export and quoted in USD, and ii) the cost structure of these producers is largely denominated in MYR.

Further, the MYR has weakened against major competing rubber gloves producing nations such as Indonesia and Thailand. This ought to  help boost competitiveness of Malaysian rubber products vs those of Indonesia and Thailand.

 

 

Our  sensitivity  analysis  indicates  that,  should  the  USD/MYR  exchange  rate strengthen  by  0.10,  Malaysian  rubber  gloves  producers  could  benefit  from  an increased earnings level of around 2-4%.

Source: RHB


 

Kossan Rubber Industries - Outlook Remains Bright

Date: 21/11/2014 

Source  :  RHB-OSK
Stock  :  KOSSAN       Price Target  :  5.12      |      Price Call  :  BUY
        Last Price  :  4.51      |      Upside/Downside  :   +0.61 (13.53%)
 

We keep our BUY recommendation and  TP  of  MYR5.12 (12.8% upside, 17x  FY15F  P/E).  9M14  earnings  came  in  weaker  than  expected  due to lower contributions from all divisions, but we see  a  bright outlook for FY15  when  its  new  lines  commence  operations.  Kossan  declared  a dividend  of  3.5 sen  in  the quarter under review. We  remain positive on the company’s future growth prospects.

Slower growth.  Kossan  Rubber Industries’ (Kossan) 9M14 net  profit  of MYR105.8m  (+3.7%  YoY)  came  in  weaker  than  our  and  consensus expectations, at 63% and 65% of the respective full-year forecasts. This was  attributed  to  lower-than-expected  sales  (-2%  YoY)  from  the technical  rubber  division  due  to  lower  exports  of  industrial  and automotive parts, although the  sales of  infrastructure  products together with  marine  and  dock  fenders  remained  strong.  Lower  average  selling prices  (ASPs)  in  the  gloves  division  due  to  lower  raw  material  pricesoffset higher  sales volume (+5.5% YoY for 3Q14).  As for  its clean-room division,  higher  operating  expenses  incurred  from  the  expansion  of  its clean-room  facilities  in  China  coupled  with  higher  staff  costs  led  to  a decline in earnings contribution. 

Outlook.  We  learnt  that  Kossan  is  currently  ramping  up its  production volume – Plant 1 is currently running at full capacity, while Plants 2 and 3 are expected to commence commercial production in Nov 2014 and Jan 2015  respectively.  Coupled  with  its  cost-control  measures  to  improve production  efficiency,  we  remain  positive  on  the  company’s  future earnings prospects. The technical rubber products division is expected to pick  up  when  supply  to  the  mass  rapid  transit  (MRT)  projects  starts,while  the  clean-room  division  is  set  to  improve  since  the  expansion investment has been completed.

Maintain  BUY.  We  trim  our  FY14  earnings  forecast  by  6%  as  full contribution from  its new plants has yet to come in, and keep our FY15 forecast unchanged. Maintain BUY with  an  unchanged TP  of  MYR5.12, based on a 17x FY15F P/E, at a  discount to Hartalega Holdings’ (HART MK, BUY, TP: MYR7.50) 21x. However, we think this is justifiable noting that Hartalega fetches a better net profit margin of  20% vs Kossan’s 11-12%,  given  the  former’s  superior  operating  efficiency  and  greater emphasis on nitrile glove production.   

 


 

 

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment